Position in MRK
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$27,942,765
+$9,535,634 QoQ
Shares Held
232,295
+32.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $434,660,167 across 16 Drug Manufacturers - General names. MRK ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
243,853 | $85,799,678 | |
| 2 | NVS |
Novartis AG
|
403,774 | $61,676,478 | |
| 3 | LLY |
ELI LILLY & Co
|
60,441 | $55,591,818 | |
| 4 | AZN |
Astrazeneca PLC
|
191,107 | $37,690,122 | |
| 5 | JNJ |
Johnson & Johnson
|
139,822 | $34,178,089 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
232,295 | $27,942,765 | |
| 7 | GSK |
GSK plc
|
480,636 | $26,526,300 | |
| 8 | SNY |
Sanofi
|
509,464 | $24,545,975 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,942,765 | 232,295 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $18,407,131 | 174,873 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $14,848,727 | 176,918 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $12,225,074 | 154,435 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $14,156,318 | 157,713 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $16,602,714 | 166,895 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $16,713,306 | 147,176 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $16,126,807 | 130,265 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $15,275,851 | 115,770 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $11,320,091 | 103,835 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $11,123,026 | 108,043 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $12,088,141 | 104,759 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,626,313 | 81,082 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $8,462,822 | 76,276 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,838,936 | 67,800 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $5,608,687 | 61,519 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $2,295,594 | 27,978 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,616,797 | 21,096 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $26,727,442 | 355,844 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $26,787,254 | 344,442 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $37,668,783 | 512,088 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $72,857,463 | 933,431 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $64,907,217 | 820,045 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $54,112,945 | 733,355 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $43,496,704 | 592,469 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||